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Kidney disease in Paraguay. Paraguay is a landlocked country
located in South America with a total population of 5,884,491.
Most of the population (95%) is mestizo, a mixture of Span-
ish and American/Indian races. The total number of indigenous
people in the country has increased from 38,703 in 1981 to 85,674
in 2002. The gross domestic product per capita was US $932.00
annually per person in the year 2002. Between 1992 and 1997,
there were 380 patients on chronic dialysis in Paraguay and 75
patients received renal transplants, mostly living-related. The
prevalence of renal replacement therapy was 87 patients per
million, and the incidence of renal disease continues to rise.
Seventy percent of cases of ESRD are of unknown etiology
and 15% have diabetes-related renal disease. Only citizens cov-
ered by the employee’s national health insurance have com-
plete coverage for dialysis and transplantation. The remain-
der of the population has to apply to public hospitals when
the need for hemodialysis arises. At such hospitals, they can
receive hemodialysis coverage from the National Institute of
Nephrology or from other medical foundations to obtain en-
trance to these programs. They must otherwise use their own
resources to pay for treatment. Seventy percent of patients on
chronic dialysis turn to public hospitals for treatment. Hospital
hemodialysis is the method most widely used. Home dialysis is
rarely performed and there are very few programs for ambu-
latory peritoneal dialysis. Thus, a large number of patients are
not able to enter chronic dialysis programs.
In a recent survey of 4655 ill children registered, the dis-
tribution of main renal disease was acute glomerulonephri-
tis in 42 cases (9 per 1000), nephrotic syndrome in 40 cases
(8.5 per 1000), systemic lupus erythematosis in 28 cases (6
per 1000), and hematuria alone in 11 cases (2.3 per 1000).
In ambulatory pediatric practice, urinary tract infection is the
leading reason for seeking medical advice. Two thirds of such
cases are associated with urinary tract anomalies. Children
with ESRD are able to enter hemodialysis programs, but there
are not sufficient resources to transplant them. Over 60% of
the children with ESRD are hospitalized with terminal re-
nal failure; malformations of the urinary tract are the usual
cause.
One study of 9880 adults aged 18 to 74 years reported that
39.1% of the women and 26.8% of the men examined were
found to have hypertension. Almost half who were found to
have raised blood pressure in this study were not previously
known to have hypertension. In another cross-sectional study
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of the urban and suburban mestizo population of Asuncion
among patients between 20 and 74 years of age, the overall
prevalence of diabetes mellitus was 6.5%, impaired glucose tol-
erance 13.5%, hypertension 17%, and obesity 31.6%. Extrapo-
lating from this data, we can assume that 178,000 patients with
hypertension in Paraguay need medical treatment.
To face the problem of growing numbers of patients with
end-stage renal failure, it is necessary to carry out basic epi-
demiologic research to detect and quantify cases early in the
course of disease, and thus propose treatments designed to slow
the progress of the disease. Without this type of data, it would
be difficult to establish an efficient action plan for improving the
development of the treatment of renal disease. Thus, we are rec-
ommending the establishment of early detection and treatment
campaigns for chronic renal disease, especially in individuals
at risk. It is also desirable to promote renal transplantation us-
ing related live donors. We need to cooperate with government
authorities to increase the insurance coverage of patients on
chronic dialysis and find the most practical ways to establish
long-term dialysis programs. A major question that is hard to
answer in practice is whether there should be universal insur-
ance for dialysis and transplantation for all who need it from
the outset, as opposed to implementation in successive stages,
which gives priority to only a minority of the population; which
could be better adapted to our financial possibilities.
Resumen
Paraguay es una nacio´n sudamericana con una poblacio´n de
5.8 millones de habitantes. La mayor parte de ellos son de raza
mestiza (95%), resultado de la mezcla de sangre espan˜ola e
indı´gena. La poblacio´n indı´gena se ha incrementado de 38,703
habitantes en 1981 a 85,674 en 2002. El producto interno bruto
per capita es de $ 932.00 do´lares americanos. Entre 1992 y
1997 se registraron 380 pacientes en dia´lisis y se practicaron
75 trasplantes renales, la mayorı´a de estos u´ltimos de donante
vivo relacionado. La prevalencia de pacientes en dia´lisis es de
87 por millo´n de habitantes y la incidencia continua al alza. En
el 70% de los casos con insuficiencia renal cro´nica (IRC) se
desconoce su etiologı´a y un 15% presenta nefropatı´a diabe´tica.
Solo aquellos individuos que poseen el seguro nacional de salud
(IPS) del trabajador, tienen cubierto su tratamiento de dia´lisis
y trasplante. Los dema´s tienen que acudir a hospitales pu´blicos
cuando ası´ lo requieran. En dichos hospitales pueden buscar el
apoyo econo´mico de otras fundaciones privadas, o bien pagar
con sus propios recursos. El 70% de los pacientes de los pa-
cientes en dia´lisis acuden a estos hospitales. La hemodia´lisis
en hospital es la terapia ma´s frecuentemente utilizada. La
hemodia´lisis en casa casi no se practica y existen escasos pro-
gramas de dia´lisis peritoneal continua ambulatoria (DPCA).
Debido a lo anterior, un porcentaje elevado de pacientes con
IRC no pueden ingresar a programas de dia´lisis cro´nica.
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En un estudio reciente de 4,655 nin˜os enfermos, se encontro´
glomerulonefritis aguda en 42 casos (9 por 1000), sı´ndrome
nefro´tico en 40 (8.5 por 1000), lupus eritematoso siste´mico en
28 (6 por 1000) y hematuria aislada en 11 (2.3 por 1000). Las
infecciones del tracto urinario son la principal patologı´a obser-
vada en el paciente ambulatorio pedia´trico y un 60% de ellas se
asocian a malformaciones del tracto urinario. Ası´ mismo, estas
u´ltimas constituyen la principal causa de IRC en este grupo.
Los nin˜os con IRC tienen acceso a programas de hemodia´lisis,
pero no se cuenta con los suficientes recursos econo´micos para
trasplantarlos.
En un estudio que incluyo´ a 9,880 adultos con edades entre
los 18 y 74 an˜os, se reporto que el 39.1% de las mujeres y el
26.8% de los hombres examinados tenı´an hipertensio´n arterial.
Ma´s de la mitad de la poblacio´n con cifras elevadas de presio´n
arterial se desconocı´a hipertensa. Otro estudio transversal real-
izado entre la poblacio´n mestiza de a´rea urbanas y suburbanas
de la capital Asuncio´n, con edad entre los 20 y 74 an˜os, reporto´
una prevalencia de diabetes mellitus del 6.5%, intolerancia a
la glucosa, 3.5%, hipertensio´n arterial, 17% y obesidad, 31.6%.
De este estudio podemos asumir que 178,000 hipertensos re-
quieren de tratamiento en Paraguay.
Con el fin de enfrentar el creciente nu´mero de pacientes con
IRC, se debera´n de realizar estudios epidemiolo´gicos encam-
inados a detectar y cuantificar el nu´mero de casos de IRC en
una etapa incipiente y aplicar medidas encaminadas a retardar
el avance de la misma. Sin esta informacio´n sera´ difı´cil el es-
tablecer un programa eficiente de prevencio´n de la IRC. Por la
anterior, se propone el establecer programas de deteccio´n tem-
prana y retardo en la progresio´n del dan˜o renal en Paraguay,
especialmente en poblacio´n de alto riesgo, ası´ como el promover
el trasplante renal, principalmente de donante vivo. En colabo-
racio´n con las autoridades gubernamentales se debera´n de en-
contrar los medios para incrementar la cobertura de dia´lisis, ası´
como la forma de establecer programas de dia´lisis de larga du-
racio´n. El dilema consiste en que si desde un inicio se debe de
implementar un acceso universal a todo aquel que lo necesite,
o bien, como sucede actualmente, implementarlo en etapas, las
cuales solo beneficiarı´an a algunos segmentos de la poblacio´n.
PARAGUAY: BASIC DATA
The total population of Paraguay is 5,884,491, and its
surface area is 406,752 square kilometers. Paraguay is a
landlocked country located in South America. It is di-
vided into 16 provinces, 3 of which are located in the
western region (also called Chaco) and the other 13 in the
eastern region. Most of the population (95%) is mestizo, a
mixture of Spanish and American/Indian races. The total
number of indigenous people in the country has increased
from 38,703 in 1981 to 85,674 in 2002. They are located
all throughout the country in different communities [1].
Paraguay has 2 official languages: Spanish and
Guarani, a native language. The gross domestic product
per capita doubled between 1962 in 2000. It reached US
$932 annually per person in the year 2002.
The Paraguayan Society of Nephrology (PSN) was
founded in Asuncion, the capital city of Paraguay, in 1971.
A full background history of nephrology in Paraguay was
detailed in a report published in 1992 [2].
Most of the population has no access to these programs,
or they can only get partial economic support for their
treatment. Furthermore, the almost exclusive concentra-
tion of nephrologists in the capital city of the country
is a major obstruction to the availability of expert help
for a large portion of the population. There are clinical
laboratories in Asuncion with resources to conduct renal
function tests and immunologic investigations on patients
with renal disease. It is also possible that more sophis-
ticated immunologic tests can be administered in both
the public and private arenas. The Pathology Division
of the Research Institute of Health Sciences, National
University of Asuncion, is a public laboratory specializ-
ing in renal pathology, which carries out full panoply of
histopathologic renal examinations. These services, how-
ever, are only available in the metropolitan area.
Specialist nephrology units were formed in major hos-
pitals after 1966. Currently, all main hospitals in Asun-
cion have nephrology departments in place. PSN has 35
nephrologists currently registered, with 4 of them work-
ing exclusively in the area of pediatric nephrology. Most
of these nephrologists completed their studies in the
United States, Europe, or neighboring countries, and they
currently work almost exclusively in Asuncion. Advances
in nephrology have been achieved for the most part by
participation in national and international congresses and
by the establishment of exchange programs.
Unfortunately, not all patients who need nephrologic
care have access to health coverage. Less than 20% of
the population carry health insurance provided by the
Instituto de Prevencion Social (Social Prevention Insti-
tute), Paraguay’s public health insurance system, which
was created in 1943. There are other governmental agen-
cies that also provide partial support for chronic renal
patients, such as the National Institute of Nephrology,
created in 1990 under the Ministry of Public Health and
Social Welfare of Paraguay. This institution is in charge
of a chronic hemodialysis program, another governmen-
tal agency, called the National Institute of Ablation and
Transplantation, which was created in 1999 and addresses
human organ and anatomic tissue transplants. The sup-
port provided by private health insurance companies
to renal patients is very restricted and, regrettably, on
many occasions, patients find themselves having to pay
for treatment they need.
The most frequent indication for renal biopsy is the
diagnosis of systemic lupus erythematosis (SLE) with re-
nal involvement. The most common type of renal injury
found in the biopsies of such patients is class IV of the
World Health Organization classification of lupus nephri-
tis. In our series, the renal biopsy of patients with SLE,
performed before starting treatment (using intravenous
cyclophosphamide; 0.5–1.0 g monthly for 6 months and
then every 3 months for 2 years), shows an activity index
of 10.1 ± 2.7 per 24 and a chronicity index of 3.1 ± 1.1 per
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Fig. 1. Effects of intravenous cyclophosphamide pulse IVC on renal
histology and function.
12 with an average serum creatinine of 1.13 ± 0.36 mg/dL.
In renal biopsies carried out after therapy, we have found
a decrease of almost 50% in activity scores, a slight dete-
rioration of the renal function reflected by a further rise
in the serum creatinine (1.49 ± 0.32 mg/dL) and by rising
chronicity scores (5.28 ± 1.55 per 12) (Fig. 1).
This increase in chronicity scores and the deterioration
of renal function have led us to the conclusion that SLE
generally presents as an aggressive lesion in our popula-
tion, or that patients seek assistance very late. Thus, it is
possible that poor prognosis of patients with proliferative
lupus nephritis may result from socioeconomic as much
as from biologic or genetic factors [3].
Class V membranous lupus nephritis is found in only
3% of patients in our series, which is well below the pro-
portion found in other reports.
Among primary glomerlonephritides, membranopro-
liferative type I glomerular nephropathy was found in
29.1% of our patients at renal biopsy and in 50% pre-
senting with impairment of renal function. Forty percent
presented with hypertension, and 70% had nephrotic syn-
drome. Some of these patients quickly evolved to end-
stage renal disease (ESRD). As in patients with lupus
nephritis, we wonder whether this represents a predom-
inantly aggressive form of the disease in our population,
or whether it is simply a case of late presentation.
In recent years, we have seen a gradual increase in the
number of patients entering long-term hemodialysis pro-
grams because of diabetic nephropathy. Currently, 15%
of the patients on chronic hemodialysis in our institu-
tion appear to have diabetes-related ESRD. However,
because not all patients with diabetes that require chronic
hemodialysis are admitted to such programs, this pathol-
ogy may be underreported among causes of ESRD in
Paraguay. A degree of renal function impairment, found
in patients with diabetes hospitalized in one of the inter-
nal medicine divisions of our hospital, lends support to the
major impact that diabetic nephropathy may be a lead-
ing cause of ESRD in Paraguay. Twenty percent of the
315 patients with diabetes hospitalized between January
1998 and December 2002 had serum creatinine values of
2 mg/dL or greater. This group included cases in which
diabetes was newly diagnosed and others in which the
disease had already been present for 5 to 15 years. Fifty
percent of patients with a 20-year history of diabetes had
serum creatinine levels exceeding 2 mg/dL. Most were
older patients with multiple pathologies (peripheral vas-
cular disease and/or coronary heart disease) who were
generally in poor health.
We have found a surprisingly low instance of im-
munoglobulin A nephropathy cases in our registry—just
2%, despite its high prevalence in other series. We have
no explanation for this finding. A low instance of im-
munoglobulin A nephropathy (0.9%) has been reported
by researchers from Peru [4]. Because there are no pre-
ventive medicine programs in the country and no peri-
odic search for microscopic hematuria in schools or the
working place, it is possible that this condition is under-
diagnosed.
HYPERTENSION
Ayala et al [5] carried out a nationwide study to deter-
mine the prevalence of hypertension to ascertain the need
for a national hypertension control program. In this study,
9880 adults 18 to 74 years of age answered a questionnaire
and then were examined (using a modified World Health
Organization definition of hypertension). Of those exam-
ined, 39.1% of the women and 26.8% of the men were
hypertensive. There was a marked age-related increase
in the prevalence of the disease. Almost half of the pa-
tients who were found to have raised blood pressure in
this study were not previously known to be hypertensive.
No indigenous patients were included in the study.
Jime´nez et al carried out a cross-sectional study of
the urban and suburban mestizo population of Asuncion
among patients between 20 and 74 years of age (N =
2000); 53.7% were from the metropolitan area and 46.3%
from surrounding towns. The object of the study was
to determine the prevalence of diabetes mellitus, im-
paired glucose tolerance, and associated cardiovascular
disease risk factors. These researchers found that over-
all prevalence was diabetes mellitus, 6.5%; impaired glu-
cose tolerance, 13.5%; hypertension, 17%; and obesity,
31.6% [6]. Extrapolating from this data, we can assume
that 178,000 patients with hypertension in Paraguay need
medical treatment.
Moreno Azorero et al studied 225 native individuals
belonging to the Ayoreo tribe located in the Paraguayan
Chaco. This study included men and women aged 18 years
or older. The prevalence of systolic hypertension was es-
timated to be 7.5%, with 5.3% of patients having raised
diastolic values [7]. The relationship between arterial
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hypertension and renal disease was not specifically ex-
amined in these studies.
In another larger and more recent study, 1717 people
from 20 native communities of the Paraguyan Chaco were
studied. The prevalence of diabetes mellitus was 5.4%,
and hypercholesterolemia was found in 15.4% of patients,
with arterial hypertension in 2.6% [8].
ACUTE RENAL FAILURE
Severe acute renal failure (ARF) cases are handled by
different medical specialties in referral hospitals. Those
patients with mild-to-moderate deterioration of renal
function are treated by internal medical services. Severe
forms of the condition are treated mainly in intensive care
units.
In 200 patients with ARF at the Hospital de Clinicas,
the main cause was sepsis. Thirty-two percent of such
cases were due to gyneco-obstetric causes. The causes
were volume depletion associated with hypotension and
hemorrhage as well as cases of acute pyelonephritis,
aminoglycoside nephrotoxicity, and contrast nephropa-
thy. We also found 6 patients with severe ARF related
to snake bite, which required intermittent hemodialysis
treatment [9].
ARF associated with severe forms of rapidly progres-
sive nephritis or systemic vasculitis is generally treated ex-
clusively with immunosuppressive therapy, because there
is no access to treatment with plasmapheresis. Less than
10% of the patients presenting with class IV lupus nephri-
tis had an acute deterioration of renal function, which
revealed crescents in 60% or more of glomeruli. After 2
years of follow-up, all patients presented with ESRD in
spite of aggressive therapy [10].
CHRONIC RENAL FAILURE AND RENAL
TRANSPLANTATION
Between the years 1992 and 1997, there were 380 pa-
tients on chronic dialysis in Paraguay, and 75 patients re-
ceived renal transplants. The prevalence of renal replace-
ment therapy was 87 patients per million. The incidence
of renal disease, however, is continuing to rise. Only citi-
zens covered by the employee’s national health insurance
have complete coverage for dialysis and transplantation.
The remainder of the population has to apply to public
hospitals when the need for hemodialysis arises. At such
hospitals, they can receive hemodialysis coverage from
the National Institute of Nephrology or from other med-
ical foundations to obtain entrance to these programs.
They must otherwise use their own resources to pay for
treatment. At this time, over 70% of patients on chronic
dialysis turn to public hospitals for treatment. Hospital
hemodialysis is the method most widely used. Home dial-
ysis is rarely performed, and there are very few programs
for ambulatory peritoneal dialysis. Thus, a large number
of patients are not able to enter chronic dialysis programs.
For example, in the emergency room of the Hospital de
Clinicas, 6500 patients were assessed between June 2002
and July 2003; 275 of these (4.25% of the total) presented
with ESRD but could not be accepted in the dialysis pro-
gram because of the shortage of available places.
Over 85% of the patients in our hospital started chronic
hemodialysis without a permanent vascular access. As
might be expected, this situation creates important medi-
cal problems and an unnecessary burden on chronic dial-
ysis costs. According to data provided by the PSN’s Reg-
istry of Dialysis and Renal Transplantation, almost 70%
of cases of ESRD are of unknown etiology—that is, they
are undiagnosed at the time of entry into the program.
Obstructive nephropathy from conditions such as be-
nign prostastic hypertrophy is an evident cause of deteri-
oration of renal function in elderly patients in Paraguay.
A proper education program about urinary tract obstruc-
tion for these patients might prevent renal function dete-
rioration in many of them.
Paraguay has shown interest in promoting renal trans-
plantation by training many nephrologists, immunolo-
gists, and urologic and vascular surgeons. There are 2
laboratories in Asuncion that are resourced to work on
transplant immunology and provide detail of the ma-
jor histocompatibility antigens for the purposes of re-
nal transplantation. Most modern immunosuppressive
agents are available within the private sector. How-
ever, not enough renal transplantation procedures can
be carried out given the number of patients awaiting that
treatment. Currently, there are 135 transplant patients
registered with the PSN. Most of the transplants were per-
formed with the assistance of living related donors. Even
though renal transplantation is regarded as the treatment
of choice for patients with ESRD, the major obstruction
in carrying it out in Paraguay is the lack of economic
resources available for the purchase of immunosuppres-
sive drugs. Table 1 shows the principle data on hemodial-
ysis in Paraguay compared with other Latin American
countries. The data are taken from the 1919 survey of the
Committee for Nephrology Development of the Latin
American Society of Nephrology and Hypertension [11].
RENAL AND RELATED DISEASE IN THE
INDIGENOUS POPULATION
Hantavirus pulmonary syndrome was described in our
country a few years ago. Of the 23 initially confirmed
cases with this syndrome, 4 were indigenous Paraguayans.
In clinical and laboratory data published on these cases,
most (17 patients) showed proteinuria [12]. Another
study among the native population of the Ayoreo commu-
nity detected 16% of hantavirus infections in 225 patients
studied. The diagnosis of the infection was made through
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Table 1. Main data on dialysis in Paraguaya
Paraguay Regionb Ranking
Patients on dialysis 500 108011 11/17
Patients on dialysis, per million 87 234 13/17
population
Gross domestic product for 0.077 0.078 9/14
dialysis expenses%
Expenditure in dialysis per inhabitant 1.69 2.68 8/15
Health expenditure for dialysis 0.97 1.06 7/14
expensesc%
% Military expenditure for 6.98 5.61 9/12
dialysis expensesc%
% Education expenditure for 0.4 0.36 8/13
dialysis expensesc%
aCommittee for the Nephrology Development of the Latin American Society
of Nephrology and Hypertension (SLANH); 1999 survey.
bRegion: 17 Latin American countries participating in the 1999 survey of
SLANH’s Committee for the Nephrology Development.
cWorld Bank Development, 2003.
detection of immunoglobulin G antihantavirus antibod-
ies. Thirty-one of 178 native Ayoreo individuals studied
for the detection of viral hepatitis were found to be hep-
atitis B surface antigen positive, which represented 17%
of the total population. In 175 individuals that were tested
for anti-hepatitis C virus antibodies, 15% were positive.
None were positive for the detection of human immun-
odeficiency virus.
NEPHROLITHIASIS
Renal stones are a frequent reason for medical consul-
tation, both in private and public practice. In particular,
renal colic is a very frequent reason for seeking medical
help in emergency rooms, especially during the summer,
when it is customary for temperatures to be above 35◦C.
The surgery of kidney and ureteral stones is carried out
by ureteroscopic lithotripsy, percutaneous nephrolitho-
tomy, or extracorporeal shock wave lithotripsy. The latter
equipment, however, is available only in private hospitals
in Asuncion. Even so, the role of open surgery for remov-
ing renal and/or ureteral stones has diminished, at least in
the metropolitan area. It is widely known that one of the
characteristics of nephrolithiasis is a relapse, which has
motivated us to implement a preventative program for it
based on the detection of underlying metabolic causes in
patients with this condition. Preliminary results of clini-
cal studies in patients with nephrolithiasis show that nor-
mocalcemic hypercalcinuria and hypocitraturia are the
causes most frequently found in our patients. These re-
sults probably cannot be extrapolated to the general pop-
ulation, because testing was largely confined to those who
could afford it (middle- and upper-class patients). At-
tention to the problem of nephrolithiasis remains impor-
tant, because in some cases it would seem that ESRD
occurs as a result of lithiasis associated with repeated re-
nal parenchymal infection.
KIDNEY DISEASE IN CHILDREN
Acute glomerulonephritis has been associated with a
large number of microorganisms. The one found most
frequently at the Hospital de Clinicas, as well as in other
centers, is the beta-hemalytic streptococcus—Lancefield
group A. Nephrotic syndrome is a common problem in
pediatric nephrology. In the last 4 years, we have reg-
istered a total of 4655 children with pediatric problems.
Distribution of the main renal disease for every 1000 chil-
dren is: acute glomerulonephritis, 42 cases (9 per 1000);
nephrotic syndrome, 40 cases (8.5 per 1000); SLE, 28 cases
(6 per 1000); and hematuria alone, 11 cases (2.3 per 1000).
In ambulatory pediatric practice, urinary tract infection is
the leading reason for seeking medical advice. Two thirds
of such cases are associated with urinary tract anoma-
lies. Children with ESRD are able to enter hemodialysis
programs, but we still do not have sufficient resources
to perform transplantations in them. Over 60% of the
children with ESRD are hospitalized with terminal renal
failure; malformations of the urinary tract are the usual
cause. ARF requiring dialysis is treated by the peritoneal
route. The principle cause of this presentation is sepsis.
FUTURE DIRECTIONS
Establishing guidelines for nephrology in Paraguay is
not an easy task. Restricted access to resources means
that long-term planning is difficult to undertake. To face
the problem of growing numbers of patients with ESRD,
it is necessary to carry out basic epidemiologic research
to detect and quantify cases early in the course of dis-
ease and, thus, propose treatments designed to slow the
progress of the disease. Without these types of data, it
would be difficult to establish an efficient action plan for
improving the development of the treatment of renal dis-
ease. Thus, we are recommending the establishment of
early detention and treatment campaigns for chronic re-
nal disease, especially in individuals at risk. In Paraguay
particularly, patients with SLE and diabetes mellitus are
at high risk for developing renal failure. Treating be-
nign prostatic hypertrophy early by surgical methods and
the appropriate management of arterial hypertension,
nephrolithiasis, and urinary tract anomalies with asso-
ciated infections are examples of cases that may very
well benefit from preventive intervention. It is also de-
sirable to promote renal transplantation with related live
donors. We need to cooperate with government author-
ities to increase the insurance coverage of patients on
chronic dialysis and find the most practical ways to estab-
lish long-term dialysis programs. A major question that
is hard to answer in practice is whether there should be
universal insurance for dialysis and transplantation for
all who need it from the outset, as opposed to implemen-
tation in successive stages, which gives priority to only a
minority of the population; this is the current practice.
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